■■Some studies have associated antenatal use of SSRIs with increased risk of a potentially fatal neonatal condition, persistent pulmonary hypertension of the newborn (PPHN). ■■This article reviews the findings for physicians and provides plain-language talking points that can be used to answer patients' questions and guide them in making informed decisions about treatment. © Copyright 2012 Physicians Postgraduate Press, Inc.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Andrade, C. (2012). Selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn. Journal of Clinical Psychiatry. Physicians Postgraduate Press Inc. https://doi.org/10.4088/JCP.12f07731